Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-002008
Filing Date
2015-02-06
Accepted
2015-02-06 15:31:24
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20141231_10q.htm 10-Q 946658
2 EXHIBIT 10.17 ex10-17.htm EX-10 111723
3 EXHIBIT 10.18 ex10-18.htm EX-10 105641
4 EXHIBIT 31.1 ex31-1.htm EX-31 18850
5 EXHIBIT 31.2 ex31-2.htm EX-31 18869
6 EXHIBIT 32.1 ex32-1.htm EX-32 12399
  Complete submission text file 0001437749-15-002008.txt   5653758

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS bota-20141231.xml EX-101.INS 868355
8 EXHIBIT 101.SCH bota-20141231.xsd EX-101.SCH 35202
9 EXHIBIT 101.CAL bota-20141231_cal.xml EX-101.CAL 29356
10 EXHIBIT 101.DEF bota-20141231_def.xml EX-101.DEF 229173
11 EXHIBIT 101.LAB bota-20141231_lab.xml EX-101.LAB 201360
12 EXHIBIT 101.PRE bota-20141231_pre.xml EX-101.PRE 248944
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 15584221
SIC: 2836 Biological Products, (No Diagnostic Substances)